Rubella, sometimes called German measles, is an acute viral infection that causes a mild illness in children and slightly more severe illness in adults. The disease is spread person-to-person through airborne particles and takes two to three weeks to incubate.
The following are the most common symptoms of rubella. However, each individual may experience symptoms differently. Symptoms may include:
Rash (usually begins at the face and progresses to the trunk and extremities and lasts about three days)
Slight fever
Enlarged lymph nodes
Headache
Rubella in pregnant women may cause serious complications in the fetus, including a range of severe birth defects.
The symptoms of rubella may resemble other medical conditions. Always consult your physician for a diagnosis.
In addition to a complete medical history and medical examination, diagnosis is often confirmed with a throat culture and blood testing.
Specific treatment for rubella will be determined by your physician based on:
Your overall health and medical history
Extent of the condition
Your tolerance for specific medications, procedures, or therapies
Expectations for the course of the condition
Your opinion or preference
Treatment for rubella is usually limited to acetaminophen for fever.
Measles, mumps, and rubella (MMR) is a combination childhood vaccination that protects against these three viruses. MMR provides immunity to most people. People who have had rubella are immune for life.
Usually, the first dose of the MMR vaccine is administered when a child is 12 months old, and a second dose is given at 4 to 6 years of age. However, if 28 days have passed since the first dose was administered, a second dose may be given before the age of four.
Treatment Programs
The following related clinical trials and research studies are currently seeking participants at Massachusetts General Hospital. Search for clinical trials and studies in another area of interest.
Mass General ensures that our patients receive the highest quality and safest care possible. Learn about our performance, our improvement goals and how we compare to other institutions.